TV L250 Pill - yellow oval
Pill with imprint TV L250 is Yellow, Oval and has been identified as Lapatinib Ditosylate 250 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Lapatinib is used in the treatment of Breast Cancer; Breast Cancer, Metastatic and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Lapatinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV L250
Lapatinib Ditosylate
- Imprint
- TV L250
- Strength
- 250 mg
- Color
- Yellow
- Shape
- Oval (film-coated)
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, HER2 inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00480-3237
More about lapatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.